A MODULATABLE SWITCH FOR SELECTION OF DONOR MODIFIED CELLS

The disclosed methods are generally directed to preventing, treating, suppressing, controlling or otherwise mitigating side effects of T-cell therapy, the T-cell therapy designed to accelerate immune reconstitution, induce a GVM effect, and/or target tumor cells.

Saved in:
Bibliographic Details
Main Authors BARTLETT, Jeffrey, BRETON, Louis Randall, SYMONDS, Geoffrey Phillip, YAN, Ming, ALMA, Christopher Walter
Format Patent
LanguageEnglish
French
German
Published 28.12.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The disclosed methods are generally directed to preventing, treating, suppressing, controlling or otherwise mitigating side effects of T-cell therapy, the T-cell therapy designed to accelerate immune reconstitution, induce a GVM effect, and/or target tumor cells.
Bibliography:Application Number: EP20180750006